Search
forResearch 7 of 145
- Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden Noac Registry (NCT01588119)
- Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- New oral anticoagulants and their reversal agents
- Rivaroxaban-induced hair loss
- Ann Robinson’s research reviews —12 May 2022
- Drug News
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →